Invesco RAFI Strategic US ETF (IUS)

The Invesco RAFI Strategic US ETF presents a compelling case for both tactical entry and long-term accumulation, driven by a powerful convergence of technical momentum and superior multi-year performance. Technically, the asset is trading well above its 50-day and 200-day moving averages, with the latter showing a robust 13% gain, indicating a healthy uptrend. The recent price action over the last two weeks confirms this strength, with the price holding firm above the $69 level and pushing toward the $70 psychological barrier, suggesting immediate bullish pressure. While the 45-day statistical forecast model offers a modest 2.41% upside prediction with high confidence, this short-term noise metric is secondary to the clear structural trend; it supports the bullish thesis rather than dictating it. From a long-term perspective, the fundamentals are exceptionally strong. The asset has delivered a staggering 115% cumulative return over the past six years, with every single year in that window posting positive gains. There is no evidence of a multi-year decline or structural deterioration; the trajectory is consistently upward. The trailing P/E of 21.4x is reasonable for a fund capturing broad market growth without the volatility of small-caps, and the consistent annualized growth suggests the underlying strategy of buying low and selling high is working effectively. This consistency warrants a high conviction rating, though it falls just short of the 'exceptional' 5-star tier reserved for businesses with 15%+ sustained revenue growth and fortress balance sheets, as the specific revenue/margin data is not explicitly detailed here despite the strong price performance. On the income side, the dividend yield sits at 1.24%. While this provides a nice cushion and regular cash flow, it is not the primary driver of value here. The payout history shows stability but lacks the aggressive growth seen in the share price, keeping the yield in a moderate, inflation-matching range rather than offering a high-income premium. Investors should view this as a bonus to capital appreciation, not the core investment thesis. Overall, this is a high-conviction play for investors seeking exposure to US equities with a focus on quality factors, currently positioned for continued upside.